According to Cassava Sciences 's latest financial reports the company's current earnings (TTM) are -$0.11 B. a decrease over its 2022 earnings that were of -$80.02 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.11 B | 32.41% |
2022 | -$80.02 M | 143.46% |
2021 | -$32.87 M | 383.92% |
2020 | -$6.8 M | 36.96% |
2019 | -$4.96 M | -25.56% |
2018 | -$6.67 M | -44.25% |
2017 | -$11.95 M | -20.11% |
2016 | -$14.96 M | 5.32% |
2015 | -$14.21 M | 14.23% |
2014 | -$12.44 M | -139.64% |
2013 | $31.36 M | |
2010 | -$13.71 M | 102.87% |
2009 | -$6.76 M | -177.52% |
2008 | $8.71 M | -14.32% |
2007 | $10.16 M | -1942.21% |
2006 | -$0.56 M | |
2004 | -$38.97 M | 75.1% |
2003 | -$22.26 M | |
2001 | -$17.32 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 4.55% | ๐บ๐ธ USA |